HALO logo
halo search icon
iBio, Inc.

US$1.89

Price Change Indicator
0.19 (11.18%)
iBio, Inc.
IBIO · NAS

iBio, Inc.

Start Trading IBIO for Free

US$1.89

Price Arrow0.19 (11.18%)
21/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusBig Candle (Realtime)EMA 125 BreakdownHALO AllHALO Consensus ValueNear SupportRecent Earnings downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

iBio, Inc. Overview

IBIO Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About IBIO

icon

Website

iBio, Inc.
icon

Telephone

1.979.446.0027

icon

Address

Suite 200, 11750 Sorrento Valley Road, San Diego, CA 92121

Description

iBio, Inc. is an AI-driven innovator that develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard to target cancers, and other diseases. It focuses on decreasing drug failures, shortening drug development timelines and opening up new frontiers against the most promising targets. The company was founded on April 17, 2008 and is headquartered in San Diego, CA.

IBIO Price Chart

Key Stats

Market Cap

US$84.45M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.56 - 3.82

Trade Value (12mth)

US$1,242,288.00

1 week

15.65%

1 month

-11.46%

YTD

-15.84%

1 year

114.38%

All time high

30300.00

Key Fundamentals

EPS 3 yr Growth

-99.90%

EBITDA Margin

NaN%

Operating Cashflow

-$15m

Free Cash Flow Return

-73.00%

ROIC

-87.70%

Interest Coverage

-82.40

Quick Ratio

1.60

Other Data

Shares Outstanding (Fully Diluted)

120m

HALO Sector

Healthcare

Next Company Report Date

29-Sep-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

IBIO Announcements

Latest Announcements

DateAnnouncements
13 May 26
13 May 26
13 May 26
13 May 26
09 May 26

IBIO Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-106.18-6.5-1.75locklocklock
EPS (Fully Diluted)
 $locklocklocklock-106.18-6.5-1.75locklocklock
Growth
 %locklocklocklock96.393.973.1locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of iBio, Inc. (IBIO:NAS)?
Halo FAQ
The current share price of iBio, Inc. (IBIO:NAS) is USD$1.89.
What is the 52-week high share price for iBio, Inc. (IBIO:NAS)?
Halo FAQ
The 52-week high share price for iBio, Inc. (IBIO:NAS) is USD$3.82.
What is the 52-week low share price for iBio, Inc. (IBIO:NAS)?
Halo FAQ
The 52-week low share price for iBio, Inc. (IBIO:NAS) is USD$0.56.
What is the dividend yield for iBio, Inc. (IBIO:NAS)?
Halo FAQ
iBio, Inc. (IBIO:NAS) does not pay a dividend.
What was iBio, Inc. (IBIO:NAS) last dividend payment?
Halo FAQ
iBio, Inc. (IBIO:NAS) does not pay a dividend.
What is the franking level for iBio, Inc. (IBIO:NAS)?
Halo FAQ
iBio, Inc. (IBIO:NAS) has a franking level of 0.00%.
In which sector is iBio, Inc. (IBIO:NAS) classified?
Halo FAQ
iBio, Inc. (IBIO:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial